NASDAQ OMX Announces Second Quarter 2009 New Listings Statistics
NASDAQ Captured 18 New Listings, Including 3 IPOS NEW YORK, July 16, 2009 (GLOBE NEWSWIRE) -- The NASDAQ OMX Group, Inc. (Nasdaq:NDAQ) today announced that The NASDAQ Stock Market(r) (NASDAQ(r)) captured a total of 18 new listings, highlighted by the initial public offerings of Chinese game devel...

Skystar Bio-Pharmaceutical Announces Expansion Plans and Growth Expectations
XI'AN, CHINA -- (Marketwire) -- 07/14/09 -- Skystar Bio-Pharmaceutical Company (NASDAQ: SKBI) ("Skystar" or the "Company"), a China-based producer and distributor of veterinary medicines, vaccines, micro-organisms and feed additives, today announced its business expansion plans and growth expectati...

Skystar Bio-Pharmaceutical Retains The Piacente Group as Strategic Investor Relations Consulting Firm
XI'AN, CHINA -- (Marketwire) -- 07/09/09 -- Skystar Bio-Pharmaceutical Company (NASDAQ: SKBI) ("Skystar" or the "Company"), a China-based producer and distributor of veterinary medicines, vaccines, micro-organisms and feed additives, today announced that it has retained The Piacente Group, Inc. ("T...

Richardson & Patel Represents Skystar Bio Pharmaceutical in $20 Million Raise
Richardson & Patel, LLP today announced that it closed a $20 million registered offering for NASDAQ company Skystar Bio Pharmaceutical (NASDAQ: SKBI), a China-based developer and distributor of veterinary healthcare and medical care products. “Over the last 9 months we’ve endured the worst...

Skystar Bio-Pharmaceutical Announces Closing of Public Offering of Common Stock
XI'AN, CHINA -- (Marketwire) -- 07/08/09 -- Skystar Bio-Pharmaceutical Company (NASDAQ: SKBI) ("Skystar" or the "Company"), a China-based producer and distributor of veterinary medicines, vaccines, micro-organisms and feed additives, today announced that it closed its previously announced public of...